STOCKNO.DE
Institutional ownership intelligence
Research
Schedule 13G/A

RNAGBP Schedule 13G/A filing by T. Rowe Price Associates

T. Rowe Price Associates reported beneficial ownership of 10.6M shares, representing 9% of AVIDITY BIOSCIENCES INC in this filing.

FiledNov 14, 2024
Ownership dateSep 30, 2024
Reported shares10.6M
Reported ownership9%
Ownership details

Voting and dispositive power reported in the filing

These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.

Sole voting power 10.4M
Shared voting power 0
Sole dispositive power 10.6M
Shared dispositive power 0
Source

Original filing and accession

Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.

Reporting filer
T. Rowe Price Associates
CIK
CIK0000080255
Accession
0000080255-24-001459
Form
Schedule 13G/A
Open SEC filing View RNAGBP ownership history
Read the filing in context

Understand what a Schedule 13 filing does—and does not—tell you.

How to read a Schedule 13G → Does a 13G mean the shares were just bought? → Filing date vs. ownership date →